Skip to main content
SpringerLink
Log in

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016)

Reply to Jean-Claude Baron Letter to Editor

  • Editorial Commentary
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Antonini A, Kazumata K, Feigin A, Mandel F, Dhawan V, Margouleff C, et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord. 1998;13(2):268–74.

    Article  CAS  PubMed  Google Scholar 

  2. Baron JC, Maziere B, Loc'h C, Sgouropoulos P, Bonnet AM, Agid Y. Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron tomography. Lancet. 1985;1:1163–4.

  3. Baron JC, Maziere B, Loc’h C, Cambon H, Sgouropoulos P, Bonnet AM, et al. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab. 1986;6:131–6.

    Article  CAS  PubMed  Google Scholar 

  4. Bhatt MH, Snow BJ, Martin WR, Peppard R, Calne DB. Positron emission tomography in progressive supranuclear palsy. Arch Neurol. 1991;48:389–91.

  5. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990;28(4):547–55.

    Article  CAS  PubMed  Google Scholar 

  6. D’Antona R, Baron JC, Samson Y, Serdaru M, Viader F, Agid Y, et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 1985;108(Pt 3):785–99.

    Article  PubMed  Google Scholar 

  7. De Volder AG, Francart J, Laterre C, Dooms G, Bol A, Michel C, et al. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann Neurol. 1989;26:239–47.

    Article  PubMed  Google Scholar 

  8. Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage. 2005;26:912–21.

    Article  PubMed  Google Scholar 

  9. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23(5):727–33.

    Article  PubMed  Google Scholar 

  10. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab. 1994;14:783–801.

    Article  CAS  PubMed  Google Scholar 

  11. Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol. 1988;24:399–406.

    Article  CAS  PubMed  Google Scholar 

  12. Gilman S, Markel DS, Koeppe RA, Junck L, Kluin KJ, Gebarski SS, et al. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol. 1988;23:223–30.

    Article  CAS  PubMed  Google Scholar 

  13. Hagberg G, Gefvert O, Bergström M, Wieselgren IM, Lindström L, Wiesel FA, et al. N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Res. 1998;82(3):147–60.

    Article  CAS  PubMed  Google Scholar 

  14. Hellwig S, Amtage F, Kreft A, Winz OH, Vach W, Spehl TS, et al. [18F]FDG-PET is superior to [123I]IBZMSPECT for the differential diagnosis of parkinsonism. Neurology. 2012;79:1314–22.

    Article  CAS  PubMed  Google Scholar 

  15. Hosaka K, Ishii K, Sakamoto S, Mori T, Sasaki M, Hirono N, et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. J Neurol Sci. 2002;199:67–71.

    Article  CAS  PubMed  Google Scholar 

  16. Ishiwata K, Hayakawa N, Ogi N, Oda K, Toyama H, Endo K, et al. Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats. Ann Nucl Med. 1999;13(3):161–7.

    Article  CAS  PubMed  Google Scholar 

  17. Ishiwata K, Ogi N, Hayakawa N, Umegaki H, Nagaoka T, Oda K, et al. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone. Nucl Med Biol. 2002;29(3):307–16.

    Article  CAS  PubMed  Google Scholar 

  18. Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur J Radiol. 2004;51(3):223–33.

    Article  PubMed  Google Scholar 

  19. Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett. 2005;383:22–7.

    Article  CAS  PubMed  Google Scholar 

  20. Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss WD. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. J Neurol. 1992;239:98–102.

    Article  CAS  PubMed  Google Scholar 

  21. Leenders KL, Frackowiak RS, Lees AJ. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain. 1988;111(Pt 3):615–30.

    Article  PubMed  Google Scholar 

  22. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55(1):97–105.

  23. Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, Lee JH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain. 2008;131:438–46.

    Article  CAS  PubMed  Google Scholar 

  24. Nagahama Y, Fukuyama H, Turjanski N, Kennedy A, Yamauchi H, Ouchi Y, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord. 1997;12(5):691–6.

    Article  CAS  PubMed  Google Scholar 

  25. Niccolini F, Politis M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging. 2016;43:2244–54. doi:10.1007/s00259-016-3464-8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ogawa M, Fukuyama H, Harada K, Kimura J. Cerebral blood flow and metabolism in multiple system atrophy of the Shy-Drager syndrome type: a PET study. J Neurol Sci. 1998;158(2):173–9.

    Article  CAS  PubMed  Google Scholar 

  27. Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Yoshida T, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson’s disease: a positron emission tomographic study. J Neurol Sci. 1996;144(1–2):77–83.

    Article  CAS  PubMed  Google Scholar 

  28. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5(4):584–90.

  29. Perani D, Bressi S, Testa D, Grassi F, Cortelli P, Gentrini S, et al. Clinical metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study. Arch Neurol. 1995;52:179–85.

    Article  CAS  PubMed  Google Scholar 

  30. Rosenthal G, Gilman S, Koeppe RA, Kluin KJ, Markel DS, Junck L, et al. Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography. Ann Neurol. 1988;24:414–9.

    Article  CAS  PubMed  Google Scholar 

  31. Takahashi R, Ishii K, Kakigi T, Yokoyama K, Mori E, Murakamic T. Brain alterations and mini-mental state examination in patients with progressive supranuclear palsy: Voxel-based investigations using 18F-Fluorodeoxyglucose positron emission tomography and magnetic resonance imaging. Dement Geriatr Cogn Dis Extra. 2011; 1(1):381–92.

  32. Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M, et al. Cerebral metabolic changes in early multiple system atrophy: a PET study. J Neurol Sci. 2002;200:79–84.

    Article  PubMed  Google Scholar 

  33. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9(2):149–58.

  34. Wagner HN, Burns HD, Dannals RF, et al. Imaging dopamine receptors in the human brain by positron tomography. Science. 1983;221:1264–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), Maurice Wohl Clinical Neuroscience Institute IoPPN, King’s College London, 125 Coldharbour Lane, London, SE5 9NU, UK

    Marios Politis

Authors
  1. Marios Politis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marios Politis.

Additional information

This Editorial Commentary refers to the article http://dx.doi.org/10.1007/s00259-016-3596-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Politis, M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016). Eur J Nucl Med Mol Imaging 44, 548–550 (2017). https://doi.org/10.1007/s00259-016-3597-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-016-3597-9

Keywords

Search

Navigation